First Korean case of a STAT1 gene mutation: chronic mucocutaneous candidiasis, hypothyroidism, chronic hepatitis and systemic lupus erythematosus |
Kim, Kang-in
(Department of Pediatrics, Soonchunhyang University Seoul Hospital)
Lee, Hanbyul (Department of Pediatrics, Soonchunhyang University Seoul Hospital) Jung, So Yoon (Department of Pediatrics, Soonchunhyang University Seoul Hospital) Lee, Dong Hwan (Department of Pediatrics, Soonchunhyang University Seoul Hospital) Lee, Jeongho (Department of Pediatrics, Soonchunhyang University Seoul Hospital) |
1 | van de Veerdonk FL, Plantinga TS, Hoischen A, Smeekens SP, Joosten LA, Gilissen C, et al. STAT1 mutations in autosomal dominant chronic mucocutaneous candidiasis. N Engl J Med 2011;365:54-61. DOI |
2 | Toubiana J, Okada S, Hiller J, Oleastro M, Lagos Gomez M, Aldave Becerra JC, et al. Heterozygous STAT1 gain-of-function mutations underlie an unexpectedly broad clinical phenotype. Blood 2016;127:3154-64. DOI |
3 | Depner M, Fuchs S, Raabe J, Frede N, Glocker C, Doffinger R, et al. The extended clinical phenotype of 26 patients with chronic mucocutaneous candidiasis due to gain-of-function mutations in STAT1. J Clin Immunol 2016;36:73-84. DOI |
4 | Dhalla F, Fox H, Davenport EE, Sadler R, Anzilotti C, van Schouwenburg PA, et al. Chronic mucocutaneous candidiasis: characterization of a family with STAT-1 gain-of-function and development of an exvivo assay for Th17 deficiency of diagnostic utility. Clin Exp Immunol 2016;184:216-27. DOI |
5 | Wang X, Zhang R, Wu W, Wang A, Wan Z, van de Veerdonk FL, et al. New and recurrent STAT1 mutations in seven Chinese patients with chronic mucocutaneous candidiasis. Int J Dermatol 2017;56:e30-3. DOI |
6 | van de Veerdonk FL, Netea MG. Treatment options for chronic mucocutaneous candidiasis. J Infect 2016;72 Suppl:S56-60. DOI |
7 | Wildbaum G, Shahar E, Katz R, Karin N, Etzioni A, Pollack S. Continuous G-CSF therapy for isolated chronic mucocutaneous candidiasis: complete clinical remission with restoration of IL-17 secretion. J Allergy Clin Immunol 2013;132:761-4. DOI |
8 | Higgins E, Al Shehri T, McAleer MA, Conlon N, Feighery C, Lilic D, et al. Use of ruxolitinib to successfully treat chronic mucocutaneous candidiasis caused by gain-of-function signal transducer and activator of transcription 1 (STAT1) mutation. J Allergy Clin Immunol 2015;135:551-3. DOI |
9 | Chun TJ, Ro BI. Chronic mucocutaneous candidiasis in Korea. Korean J Med Mycol 1999;4:104-8. |
10 | Choi KH, Kim HS, Kim HO, Park YM. Familial chronic mucocutaneous candidiasis. Korean J Med Mycol 2009;14:28-32. |
11 | Park JH, Yoo CS, Kil MS, Kim CW, Kim SS, Kim KH. A case of chronic mucocutaneous candidiasis occurring in a patient with scrofuloderma-like BCGitis. Korean J Med Mycol 2010;15:175-81. |
12 | Lee HK, Seo SJ, Ro BI. A case of chronic mucocutaneous candidiasis. Ann Dermatol 1995;7:62-5. DOI |
13 | Liu L, Okada S, Kong XF, Kreins AY, Cypowyj S, Abhyankar A, et al. Gain-of-function human STAT1 mutations impair IL-17 immunity and underlie chronic mucocutaneous candidiasis. J Exp Med 2011;208:1635-48. DOI |
14 | Soltesz B, Toth B, Shabashova N, Bondarenko A, Okada S, Cypowyj S, et al. New and recurrent gain-of-function STAT1 mutations in patients with chronic mucocutaneous candidiasis from Eastern and Central Europe. J Med Genet 2013;50:567-78. DOI |
15 | Smeekens SP, Plantinga TS, van de Veerdonk FL, Heinhuis B, Hoischen A, Joosten LA, et al. STAT1 hyperphosphorylation and defective IL12R/IL23R signaling underlie defective immunity in autosomal dominant chronic mucocutaneous candidiasis. PLoS One 2011;6:e29248. DOI |
16 | Liang Y, Xu WD, Yang XK, Fang XY, Liu YY, Ni J, et al. Association of signaling transducers and activators of transcription 1 and systemic lupus erythematosus. Autoimmunity 2014;47:141-5. DOI |
17 | Conti HR, Shen F, Nayyar N, Stocum E, Sun JN, Lindemann MJ, et al. Th17 cells and IL-17 receptor signaling are essential for mucosal host defense against oral candidiasis. J Exp Med 2009;206:299-311. DOI |
18 | Takezaki S, Yamada M, Kato M, Park MJ, Maruyama K, Yamazaki Y, et al. Chronic mucocutaneous candidiasis caused by a gain-of-function mutation in the STAT1 DNA-binding domain. J Immunol 2012;189:1521-6. DOI |
19 | Hori T, Ohnishi H, Teramoto T, Tsubouchi K, Naiki T, Hirose Y, et al. Autosomal-dominant chronic mucocutaneous candidiasis with STAT1-mutation can be complicated with chronic active hepatitis and hypothyroidism. J Clin Immunol 2012;32:1213-20. DOI |
20 | Frans G, Moens L, Schaballie H, Van Eyck L, Borgers H, Wuyts M, et al. Gain-of-function mutations in signal transducer and activator of transcription 1 (STAT1): chronic mucocutaneous candidiasis accompanied by enamel defects and delayed dental shedding. J Allergy Clin Immunol 2014;134:1209-13.e6. DOI |